Hypoxia and hypoxia inducible factors in cancer stem cell maintenance.
暂无分享,去创建一个
[1] J. Engh,et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α , 2009, Oncogene.
[2] R. McLendon,et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.
[3] D. Gisselsson,et al. HIF-2α maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells , 2009, Proceedings of the National Academy of Sciences.
[4] T. Ichisaka,et al. Hypoxia enhances the generation of induced pluripotent stem cells. , 2009, Cell stem cell.
[5] E. Barbier,et al. PO(2) matters in stem cell culture. , 2009, Cell stem cell.
[6] K. Nathanson,et al. HIF2α inhibition promotes p53 pathway activity, tumor cell death, and radiation responses , 2009, Proceedings of the National Academy of Sciences.
[7] Hui Wang,et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.
[8] E. Grande,et al. Notch signalling in cancer stem cells , 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[9] M. Celeste Simon,et al. The impact of O2 availability on human cancer , 2008, Nature Reviews Cancer.
[10] Linda Holmquist Mengelbier,et al. Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. , 2008, Cancer research.
[11] R. Hammer,et al. White Fat Progenitor Cells Reside in the Adipose Vasculature , 2008, Science.
[12] J. García-Verdugo,et al. A specialized vascular niche for adult neural stem cells. , 2008, Cell stem cell.
[13] B. Roysam,et al. Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. , 2008, Cell stem cell.
[14] S. Baldus,et al. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. , 2008, Neoplasia.
[15] Thomas C Chen,et al. Human colon cancer stem cells locate in hypoxic niche , 2008 .
[16] Jiwang Zhang,et al. Stem Cell Niche: Microenvironment and Beyond* , 2008, Journal of Biological Chemistry.
[17] P. Chambon,et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling , 2008, Nature.
[18] S. Morrison,et al. Uncertainty in the niches that maintain haematopoietic stem cells , 2008, Nature Reviews Immunology.
[19] Kou-Juey Wu,et al. Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.
[20] R. Gilbertson,et al. Making a tumour's bed: glioblastoma stem cells and the vascular niche , 2007, Nature Reviews Cancer.
[21] Y. Nabeshima,et al. A Vasculature-Associated Niche for Undifferentiated Spermatogonia in the Mouse Testis , 2007, Science.
[22] Qun Qian,et al. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma , 2007 .
[23] Linheng Li,et al. Disrupting the Stem Cell Niche: Good Seeds in Bad Soil , 2007, Cell.
[24] P. Vaupel,et al. Hypoxia in cancer: significance and impact on clinical outcome , 2007, Cancer and Metastasis Reviews.
[25] John D Gordan,et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. , 2007, Cancer cell.
[26] P. Sánchez,et al. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.
[27] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[28] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[29] Å. Borg,et al. Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. , 2006, Cancer cell.
[30] Qiulian Wu,et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.
[31] M. Ashcroft,et al. Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. , 2006, Cancer research.
[32] J. Pouysségur,et al. Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.
[33] Brian Keith,et al. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. , 2006, Genes & development.
[34] U. Lendahl,et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.
[35] E. Fredlund,et al. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.
[36] P. Carmeliet,et al. Genetic evidence for a tumor suppressor role of HIF-2alpha. , 2005, Cancer cell.
[37] L. Huang,et al. Differential Gene Up-Regulation by Hypoxia-Inducible Factor-1α and Hypoxia-Inducible Factor-2α in HEK293T Cells , 2005 .
[38] Daniel J Brat,et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. , 2005, Neuro-oncology.
[39] R. Roberts,et al. Low O2 tensions and the prevention of differentiation of hES cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[40] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[41] M. Simon,et al. Expansion of human SCID-repopulating cells under hypoxic conditions. , 2003, The Journal of clinical investigation.
[42] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[43] Yuichi Makino,et al. Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression , 2001, Nature.
[44] P. O’Farrell. Faculty Opinions recommendation of Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. , 2001 .
[45] P. O’Farrell. Faculty Opinions recommendation of HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. , 2001 .
[46] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[47] A. Harris,et al. Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival , 2001, British Journal of Cancer.
[48] W M Miller,et al. Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. , 2001, Biophysical journal.
[49] M. Ivan,et al. HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.
[50] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[51] Nadine Kabbani,et al. Enhanced Proliferation, Survival, and Dopaminergic Differentiation of CNS Precursors in Lowered Oxygen , 2000, The Journal of Neuroscience.
[52] P. W. Conrad,et al. EPAS1 trans-Activation during Hypoxia Requires p42/p44 MAPK* , 1999, The Journal of Biological Chemistry.
[53] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[54] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[55] Y Fujii-Kuriyama,et al. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[56] M. Dewhirst,et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. , 1996, Cancer research.
[57] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[58] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.
[59] Zhi-su Liu,et al. Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma. , 2007, World journal of gastroenterology.
[60] L. Huang,et al. Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. , 2005, Cancer research.
[61] Adrian L. Harris,et al. Hypoxia — a key regulatory factor in tumour growth , 2002, Nature Reviews Cancer.